Introduction
The Shc family of docking proteins plays an essential role in leading cellular signaling to specific downstream molecules such as the Ras-ERK pathway and the phosphatidylinositol 3-kinase (PI3 K)-Akt pathway when recruited towards phosphotyrosine residues of various activated RTKs. In mammals, three shc genes have been identified, and their products have been termed ShcA/Shc, ShcB/Sli/Sck and ShcC/Rai/N-Shc (Nakamura et al., 1996a; O'Bryan et al., 1996b; Pelicci et al., 1996) . ShcA is ubiquitously expressed in most organs except the adult neural system, whereas ShcB and ShcC proteins are selectively expressed in the neural system within adult mouse tissues.
The Shc family molecules have a unique PTB-CH1-SH2 modular organization. Two phosphotyrosine-binding modules, PTB and SH2 domains, recognize phosphotyrosine-containing polypeptides such as cytoplasmic domains of various activated RTKs (Pelicci et al., 1992; van der Geer et al., 1995) . The CH1 domain has several tyrosine phosphorylation sites that recruit other SH2-containing adaptor molecules such as Grb2 (van der Geer et al., 1996; Thomas and Bradshaw, 1997) and a proline-rich stretch of ShcA composing the binding site for the SH3 domains of other proteins including Src, Fyn and Lyn (Weng et al., 1994; Wary et al., 1998) . There might be difference in the molecular functions of each Shc family member, although there is not much information on individual roles of Shc families in the neural system and neuronal tumors.
We have recently shown that the expression and tyrosine phosphorylation of Shc family proteins, especially ShcC, are observed in most neuroblastoma cells. Stable association of constitutively activated anaplastic lymphoma kinase (ALK) with the ShcC has been observed in several neuroblastoma cell lines that have extremely high phosphorylation levels of ShcC (Miyake et al., 2002) . These cell lines showed malignant phenotypes as for tumorigenicity in nude mice or soft agar colony assay, and notably, ShcC expression is low compared with other neuroblastoma in spite of significantly high phosphorylation state. The ALK gene locus was significantly amplified in these cell lines, which results in the constitutive activation of the ALK and most prominent tyrosine phosphorylation of ShcC among several known binding partners of ALK such as PLCg and IRS-1 (Miyake et al., 2002) .
ALK protein has the typical structure of an RTK classified into the insulin receptor superfamily. It is dominantly expressed in the normal neural system (Iwahara et al., 1997; Morris et al., 1997) , although the biological role of this protein in neuronal cells has not yet been clearly identified. We detected remarkable amplification of the ALK gene in three out of 13 neuroblastoma cell lines (Miyake et al., 2002) and a less significant gain of copy numbers in eight out of 85 primary neuroblastoma tissues (Hakomori et al., manuscript in preparation), most of which accompany the amplification of the N-myc gene. The three ALKamplified neuroblastoma cell lines showed constitutive activation of full-length ALK and the increased local concentration of receptor tyrosine kinases appeared to interfere with signals from other RTKs. It is possible that ALK-ShcC signal activation has additional effects on the malignant tumor progression of neuroblastoma, probably similar to the mechanism reported in EGFR and Neu/ErbB2 (Andrechek et al., 2000; Pawson et al., 2001) .
To clarify the role of hyperphosphorylated ShcC in neuroblastoma cells, the 3YF-ShcC mutant, which has phenylalanines at three Grb2-binding tyrosines (Y221/ 222/304) of ShcC, was utilized in this study in the expectation of a dominant-negative effect specific for signals originating from the ShcC-Grb2 complex. The biological effects of the 3YF-ShcC mutant as well as wild-type ShcC and the DSH2 ShcC mutant, which lacks the SH2 domain, were analysed to elucidate both Grb2-dependent and -independent functions of ShcC in neuroblastoma.
Results

Suppression of ERK1/2 and Akt activation in NB-39-nu cells by expression of 3YF-ShcC
A neuroblastoma cell line, NB-39-nu, was used in this study because it shows high tumorigenicity and anchorage independency with prominent phosphorylation level of ShcC caused by constitutively activated ALK kinase. The expression level of ShcC is relatively low among the neuroblastoma cell lines examined in our previous study. T7-tagged ShcC constructs containing the full length of human ShcC cDNA (ShcC-wt), a tyrosine-to-phenylalanin mutant for all three putative Grb2-binding sites (3YF-ShcC), and the SH2-deletion mutant (DSH2-ShcC) were subcloned into a mammalian expression vector, pcDNA3.1. Multiple independent clones of NB-39-nu cell lines stably expressing these ShcC mutants at comparable levels were selected and submitted to biochemical and biological analysis. Results of representative clones are shown in Figure 1a , although basically same results were obtained from other independent clones (data not shown). Tyrosine phosphorylation of the 3YF-ShcC was significantly suppressed suggesting that the three tyrosines lost in this mutant are the main phosphorylation sites of ShcC in NB-39-nu ( Figure 1a ). As expected, the complex formation of 3YF-ShcC with Grb2 was impaired, regardless of EGF stimulation, compared with that of ShcC-wt and DSH2-ShcC (Figure 1c) . The activation level of ERK1/2 at 5 min after the EGF stimulation was decreased by expression of 3YF-ShcC, while expression of ShcC-wt or DSH2-ShcC did not affect the levels of ERK1/2 activation compared with the control cells transfected only by expression vector (mock) (Figure 1d ). The phosphorylation level of Akt at Ser-473 was also suppressed by expression of 3YF-ShcC, although not at a similar level as that of cells treated with Wortmannin (Sigma), a PI3K inhibitor (Figure 1e ). These analyses were performed using at least two independent clones. It was confirmed that 3YF-ShcC-expression has a dominant-negative effect on the PI3K/Akt pathway as well as the Ras/ERK pathway in this neuroblastoma cell line.
Expression of 3YF-ShcC increased susceptibility to retinoic acid (RA)-induced apoptosis in NB-39-nu cells There were no obvious differences in growth rate among the NB-39-nu clones expressing each ShcC mutant (Figure 2a) , whereas the rate of [ 3 H]-thymidine incorporation of the cell lines expressing 3YF-ShcC was slightly lower than that of other cells (Figure 2b) .
The cytological analyses of the cells cultured with 10 mM of all-trans-RA revealed that 3YF-ShcC expressing cells were more susceptible to RA-induced apoptosis than the control or ShcC-wt-expressing cells (Figure 3a) . Treatment of NB-39-nu cells, especially ShcC-wt-expressing cells, with RA at a lower concentration of 2.5 or 5 mM induced mild neurite formation, flattened, substrate-adherent cells resembling epithelial cells within 48 h (Figure 3b ), which is known to be a characteristics of RA-induced morphologic differentiation (Sidell et al., 1983) . In contrast, this type of differentiation was not observed in 3YF-ShcC-expressing cells. Along with the suppressive effects of 3YF-ShcC to the Akt pathway (Figure 1e ), these results suggest that phosphorylated ShcC plays significant role in survival signals through the putative Grb2-binding sites in NB-39-nu cells.
ShcC plays a distinct role in the migration of ALK-ShcCactivated neuroblastoma cells Expression of 3YF-ShcC significantly suppresses cell migration ability as shown by the wound-healing assay (Figure 4a) . A modified Boyden chamber cell-migration assay without Matrigel using fibronectin as a chemoattractant showed the results consistent with those obtained in the wound-healing assay (Figure 4b) . A similar assay with Matrigel coating on a chamber filter to evaluate the chemotactic invasive activity of each transfectant also showed decreased invasive activity in 3YF-ShcC-expressing cells (Figure 4c ). In contrast, ShcC-wt expression increased the migration ability of NB-39-nu cells both in wound healing assay and modified Boyden chamber assay without Matrigel (Figure 4a, b) , while the DSH2-ShcC expression presented no remarkable effects on the cell motility. The invasive activity of ShcC-wt-expressing cells was not significantly high compared to that of the control or of the DSH2-ShcC-expressing cells (Figure 4c ).
Expression of ShcC-wt or 3YF-ShcC has a negative effect on the transforming activity of NB-39-nu cells Cells expressing ShcC-wt or 3YF-ShcC tend to grow to confluence with a monolayer appearance, making a clear Domain-specific function of ShcC docking protein I Miyake et al difference from original NB-39-nu cells that tend to form cell aggregations on the culture dishes ( Figure 5a ). In addition, control NB-39-nu cells and DSH2-ShcCexpressing cells form a considerable number of colonies in soft agar (Figure 5b ), which is significantly suppressed by the expression of ShcC-wt or 3YF-ShcC (Figure 5b ). These results indicate that ShcC-wt or 3YF-ShcC have inhibitory effect on the transforming activity of NB-39-nu cells, especially anchorage-independent growth. Since the overexpression of ShcC had no significant effect on the activation of ERK1/2 or Akt in our experiment, it was suggested that a unique signaling pathway rather than classical Grb2-Ras pathway is involved in this phenomenon.
Src family kinases (SFKs) are well known to be associated with the ability to induce cellular transformation including anchorage independency (Parsons and Weber, 1989; Windham et al., 2002) . During the investigation of ShcC mutant cells in the suspension state, we noticed that the sustained activation of both Fyn and c-Src observed in the control cells and DSH2-ShcC-expressing cells was suppressed by the expression of ShcC-wt or 3YF-ShcC (Figure 6a , b) at 24 h after cell detachment. Especially, the condition of phosphorylation of Fyn at suspension culture well correlated with anchorage independency of NB-39-nu sublines ( Figure 6a ). Tendency of phosphorylation of Src Tyr-416, which indicates the kinase activation of SFKs, is consistent with these results (Figure 6c ). Phosphorylation of Cas, a main substrate of SFKs, in a suspended condition has recently been associated with the anchorage-independent growth of cancer-like lung adenocarcinoma (Wei et al., 2002) . Sustention and temporary elevation of the Cas phosphorylation was also observed specifically in the original NB-39-nu cells, control and DSH2-ShcC-expressing cells, whereas there was a marked decrease of the phosphorylation level of Cas in ShcC-wt-and 3YF-ShcC-expressing cells (Figure 6d , e). Treatment of NB-39-nu control cells with PP2, a Srcspecific inhibiter, suppressed the phosphorylation of Cas both in an attached and suspended condition, suggesting that the anchorage-independent phosphorylation of Cas is associated with the activity of the SFKs (Figure 6f ).
The activation of ERK1/2 or Akt was similarly suppressed by suspension culture for 24 h regardless of the expression of each ShcC mutants although the basal Figure B) . In summary, it was confirmed in this system that the constitutive activation of SFKs, such as Fyn and c-Src, and phosphorylation of Cas in suspended cells, but not other components of integrin signals such as FAK, is strictly linked to the anchorage independency of NB-39-nu cells, closely related with ShcC mutants expression. Furthermore, we detected interaction between ShcC-wt and some of SFKs following the stimulation (Figure 6g ), indicating a novel biological interaction of ShcC with SFK, as suggested for ShcA in integrin pathway (Wary et al., 1996; Giancotti, 1997) Loss of tumorigenicity of NB-39-nu-expressing ShcC-wt or 3YF-ShcC in mouse subcutaneous tissues
To investigate these antitransforming effects of ShcC-wt and 3YF-ShcC in vivo, the tumorigenicity of NB-39-nu cells expressing each mutant in nude mice was evaluated. Tumors generated by eight independent injections of each mutant were analysed in weight and histology at 4 weeks after subcutaneous injection. The results revealed a marked reduction in sizes of tumors from the cells expressing either ShcC-wt or 3YF-ShcC at this time, but not of tumors from the control cells or cells expressing DSH2-ShcC (Figure 7a ). The tumors from the control, ShcC-wt-expressing and DSH2-ShcC-expressing cells presented a hypervascular appearance (Figure 7a: upper panel) , which has the histological characteristics of almost equal-sized cells with a regular arrayed pattern, high nuclear-to-cytoplasmic (N/C) ratio and chromatin-rich nucleuses (Figure 7b ). On the other hand, the tumors from the 3YF-ShcC-expressing cells were hypovascular and histologically distinct from the other mutants, showing rather unequal-sized cells with an irregular arrayed pattern, a lower N/C ratio, few mitosis and decreased nucleus density. In accordance with this, staining by a proliferation marker, Ki-67, or a mitotic activity marker, cyclin A, markedly decreased in the tumors from 3YF-ShcC-expressing cells (Figure 7b) , showing that the cell cycle progression was significantly suppressed by 3YF-ShcC in vivo, compared with the analysis by [
3 H]-tymidine incorporation in vitro (Figure 2b ). TUNEL staining showed no marked difference in cell apoptosis among each tumor tissue (data not shown). These results suggest that the antitumorigenic activity of the 3YF-ShcC-expressing cells in vivo accompanies the regulation of cell proliferation, which is distinct from the impairment of tumorigenicity by expression of ShcC-wt.
Discussion
In our previous report, the biological effects of constitutively activated signals of ALK-ShcC on the tumorigenesis of neuroblastoma cells remain to be investigated. Here, we demonstrated that the proliferation, survival and cell migration of these neuroblastoma cells were dependent on the signals via ShcC-Grb2 pathway, downstream of ALK. Additionally, overexpressed ShcC has a suppressive effect on the anchorage-independent growth of these cells via its SH2 domain and this regulation is closely associated with the regulation of c-Src and Fyn tyrosine kinases.
The fact that 3YF-ShcC significantly suppressed the activity of both ERK1/2 and Akt, suggesting that ShcC, among signaling pathways originating from activated ALK, predominantly regulates these signals through from an experiment performed in triplicate. NB-39-nu clones are described as: v1 and v2 (control), w1 and w2 (expressing ShcCwt), m1 and m2 (expressing 3YF), d1 and d2 (expressing DSH2) Domain-specific function of ShcC docking protein I Miyake et al binding to Grb2. Our recent study also shows that the suppression of activated ALK using the RNA interference technique (RNAi) reduces the phosphorylation of ShcC, ERK1/2 and Akt, and induces the apoptotic cell death of NB-39-nu cells (Hakomori et al., manuscript in preparation). The ERK and Akt pathways are key regulators of cell proliferation, survival and differentiation. Cells expressing 3YF-ShcC become more susceptible to RA-induced apoptosis presumably due to inhibition of the Akt pathway. It has recently been shown that ShcC is physiologically involved in the regulation of the PI3K/Akt pathway as a downstream effecter of the ligand-stimulated Ret receptor in neuroblastoma cells (Pelicci et al., 2002) . This study confirms that the survival of NB-39-nu cells is regulated by the signals downstream of ShcC. The 3YF-ShcC also causes inhibition of cell motility, while overexpressed ShcC significantly increases the ability of cell migration, indicating that ShcC positively affects the regulation of cell migration. Previously, ShcA was shown to be closely related with cell motility via the MAPK pathway (Collins et al., 1999; Gu et al., 1999) , but the association of ShcC with the ability of cell migration has not been investigated.
The expression of 3YF-ShcC had a suppressive effect on the proliferation of NB-39-nu cells cultured in vitro and more significantly on the cell cycle progression of the nude mouse tumor. These data suggest that ShcC positively regulates the cell proliferation of neuronal tumor cells as well as ShcA, which has been reported to affect the tumor growth in nude mice using breast cancer cell lines (Stevenson et al., 1999) .
The overexpression of ShcC-wt endowed NB-39-nu cells with several characteristics. Other than the enhancement of cell migration and neurite outgrowth, which is consistent with previous study (Collins et al., 1999; Pelicci et al., 2002) , the observation that ShcC-wtexpressing cells were impaired for anchorage-indepen- Domain-specific function of ShcC docking protein I Miyake et al dent growth and tumorigenicity suggests a novel function of ShcC. Taking into account that the expression of 3YF-ShcC but not DSH2-ShcC showed similar effects, the SH2 domain of ShcC may be responsible for this unique function of ShcC, distinct from ShcA. In addition, the least changes in ERK1/2 or Akt activation by overexpression of ShcC-wt suggest that this function might be independent of phosphorylation of Grb2-binding sites or the activation levels of downstream targets. There are reports showing different binding specificity towards phosphotyrosine-containing motifs among Shc families (O'Bryan et al., 1996a, b; Pelicci et al., 1996) . It is crucial to identify the molecules associating with the SH2 domain of ShcC in neuroblastoma cells to elucidate the mechanism of these SH2-mediated effects of ShcC.
The smaller size of the nude mouse tumors due to the expression of ShcC-wt, regardless of mild changes in cell proliferation as both tumor tissue and culture cells, may also reflect suppression of anchorage independency (Freedman and Shin, 1974; Kumar, 1998) , which results in the loss of the majority of the injected cells by anoikis before they start forming tumors. The anchorage independency of NB-39-nu mutants well corresponded to the sustained phosphorylation levels of c-Src, Fyn and Cas after cell detachment, suggesting that the expression of ShcC-wt has a negative effect on anchorage independency due to the suppression of the SFK-Cas pathway (Figure 6 ). It is possible that ShcC-SH2 plays a competitive role with YDYV in the Srcbinding domain of Cas, judging from the consensus motifs binding to ShcC-SH2 (O'Bryan et al., 1996a, b) , although this association was not detected by usual immunoprecipitation experiments (data not shown). On the other hand, the fact that ShcC forms the complex with SFK in this study indicates that there might be a role of association between SFK and ShcC in the regulation of tyrosine kinase activity of SFK. The fact that malignant neuroblastoma cell lines with hyperphosphorylated ShcC frequently have lower expression level of ShcC (Miyake et al., 2002) might indicate additive effects of hyperphosphorylation and downregulation of ShcC on phenotype of neuroblastoma. There is the possibility that an unknown mechanism causes downregulation of ShcC, which is hyperphosphorylated by receptor stimulation, and eventually induces malignant transition of tumors.
We have shown in this study that hyperphosphorylated ShcC in neuroblastoma cells plays an essential role in regulating cellular proliferation, survival, migration and transformation, and each domain of ShcC might differentially regulate these physiological functions. Controlling these domain-mediated signals could be a target in restricting the progression and metastasis of neuroblastoma cells.
Materials and methods
Plasmid constructions
The full-length human ShcC cDNA for transfection was donated by Dr T Nakamura (Nakamura et al., 1996b) , and inserted into a mammalian expression vector pcDNA3.1.
Tyrosine-to-phenylalanine mutations were introduced in the ShcC cDNAs by in vitro site-directed mutagenesis, which changed Y221/222 and Y304 to three phenylalanines (3YF-ShcC). The SH2 domain (amino acid 379-472)-deleted form of ShcC (DSH2-ShcC) was also generated. All parts amplified by PCR were verified by sequencing.
Cell culture, transfection NB-39-nu cells were used in our previous report (Miyake et al., 2002) . The stable expression of ShcC mutants, the full-length of ShcC (ShcC-wt), 3YF-ShcC and DSH2-ShcC in NB-39-nu cells were obtained by transfection using Fugenet 6 transfection reagent (Roche Molecular Biochemicals) according to the manufacturer's instructions. Then, cell clones were obtained from individual G418-resistent colonies and subjected to Western blot screening using the T7 tag antibody (Novagen). These cells were cultured in an RPMI 1640 medium with 10% FCS (Sigma) at 371C in 5% CO 2 . A suspension culture of the cells was essentially performed according to a previously published procedure (Folkman and Moscona, 1978; Frisch and Francis, 1994; Wang and Sheibani, 2002) . In this study, LOW-CELL-BINDING 90 mm-Petri dishes treated with 2-Methacryloxyethyl Phosphorylcholine (MPC) (Nalge Nunc International) were used instead of poly-HEMA-coated dishes. Preparation of specific antibodies, cell stimulation, immunoprecipitation and immunoblotting
The polyclonal antibodies against the CH1 domains of ShcC (amino acid 306-371) and against Cas protein (aCas) were prepared as described (Sakai et al., 1994 (Sakai et al., , 2000 . A phospho specific polyclonal antibody against Cas (aP-Cas460Y) was generated by immunizing rabbits with a synthetic peptide, CAEDV(pY)DVP, which is a representative of the repetitive tyrosine-containing motifs in the substrate domain of Cas, after being conjugated with thyroglobulin. Other antibodies were purchased as follows: anti-phosphotyrosine antibody (4G10) (Upstate Biotechnology, Inc), anti-p44/42 MAPK (ERK1/2) and anti-phospho-p44/42 MAPK (phospho-ERK1/2) antibodies (BioLabs), anti-Akt and anti-phospho-Akt (Ser473) antibodies (Cell Signaling), anti-c-Src antibody (Upstate Biotechnology, Inc.), anti-phospho Src family (Tyr416) antibody (Cell Signaling), anti-Fyn antibody and anti-pan-Src antibody (SRC2) (SantaCruz Biotechnology, Inc.). As secondary antibodies, horseradish peroxidase (HRP)-conjugated antirabbit and anti-mouse Ig (Amersham) were used. Cellstimulation analysis with epidermal growth factor (EGF; Wako) was performed as described. The cells were starved for 24 h and treated for 5 min with EGF (100 ng/ml) (Miyake et al., 2002) . As for stimulation with fibronectin, cultured cells were starved for 24 h then trypsinized without FCS and after the suspending condition for 30 min, seeded onto fibronectin (10 mg/ml)-coated dishes and harvested after 1 h using PLC lysis buffer. Control cells were harvested before the attachment on the fibronectin-coated surface. The immunoprecipitation and Western analysis were performed using the procedure described in the previous report (Miyake et al., 2002) .
Evaluation of tendency to form cell aggregations on dish surface
Cells were seeded onto plastic dishes (1 Â 10 6 cells per 100-mm diameter dish). After 5 days, distinctive colonies of cell aggregations proliferated independently of the attachment to the dish surface, and each of them consisted of more than 10 cells per dish. The data were obtained from three independent experiments.
Soft agar colony-formation assay
Anchorage-independent growth was determined by assaying colony formation in soft agar as described in the previous report (Honda et al., 1998) . Briefly, 10 5 trypsinized cells were resuspended in DMEM containing 10% FCS and 0.4% Sea Plaque GTG agarose (Bioproduct) and poured onto bottom agar containing 10% FCS and 0.53% agarose in 6-cm culture dishes. The cells were then incubated at 371C with 5% CO 2 . After 14 days, colonies containing more than five cells were counted under the microscope.
